CVC Makes Partial Exit From Jintian Pharmaceutical Group

This Data Is Locked!

This area is available only to Subscribers.

London-based US$46 billion-under-management private equity firm CVC Capital Partners is selling 186 million shares in China’s Jintian Pharmaceutical Group for as much as HK$620 million... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?